Recent Developments in Cholinesterases Inhibitors for Alzheimer's Disease Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|25|2654-2679

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.25, 2007-10, pp. : 2654-2679

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 22, 2011-11 ,pp. : 2807-2823

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 6, 2015-07 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite